Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Search Results to Brett Michael Stevens

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Stevens, Brett

Item TypeName
Concept Leukemia, Myeloid, Acute
Concept Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Academic Article Tyrosine kinase inhibition in leukemia induces an altered metabolic state sensitive to mitochondrial perturbations.
Academic Article MLL1 and DOT1L cooperate with meningioma-1 to induce acute myeloid leukemia.
Academic Article Leukemic Stem Cells Evade Chemotherapy by Metabolic Adaptation to an Adipose Tissue Niche.
Academic Article Evolution of acute myelogenous leukemia stem cell properties after treatment and progression.
Academic Article Rational Design of a Parthenolide-based Drug Regimen That Selectively Eradicates Acute Myelogenous Leukemia Stem Cells.
Academic Article Rational design of a parthenolide-based drug regimen that selectively eradicates acute myelogenous leukemia stem cells.
Academic Article AMPK/FIS1-Mediated Mitophagy Is Required for Self-Renewal of Human AML Stem Cells.
Academic Article Characterization and targeting of malignant stem cells in patients with advanced myelodysplastic syndromes.
Academic Article Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia.
Academic Article Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells.
Academic Article Low ferroportin expression in AML is correlated with good risk cytogenetics, improved outcomes and increased sensitivity to chemotherapy.
Academic Article Sequential azacitidine and lenalidomide for patients with relapsed and refractory acute myeloid leukemia: Clinical results and predictive modeling using computational analysis.
Academic Article Cysteine depletion targets leukemia stem cells through inhibition of electron transport complex II.
Academic Article Real-world experience of venetoclax with azacitidine for untreated patients with acute myeloid leukemia.
Academic Article Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia.
Academic Article Nicotinamide Metabolism Mediates Resistance to Venetoclax in Relapsed Acute Myeloid Leukemia Stem Cells.
Academic Article Enriching for human acute myeloid leukemia stem cells using reactive oxygen species-based cell sorting.
Academic Article Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells.
Academic Article Venetoclax and azacitidine compared with induction chemotherapy for newly diagnosed patients with acute myeloid leukemia.
Academic Article The STAT3-MYC axis promotes survival of leukemia stem cells by regulating SLC1A5 and oxidative phosphorylation.
Academic Article Machine Learning-Based Exploratory Clinical Decision Support for Newly Diagnosed Patients With Acute Myeloid Leukemia Treated With 7 + 3 Type Chemotherapy or Venetoclax/Azacitidine.
Academic Article Venetoclax response prediction in acute myeloid leukemia: are we Finnish-ed with uncertainty?
Academic Article Therapy-Resistant Acute Myeloid Leukemia Stem Cells Are Resensitized to Venetoclax + Azacitidine by Targeting Fatty Acid Desaturases 1 and 2.
Academic Article Higher-dose venetoclax with measurable residual disease-guided azacitidine discontinuation in newly diagnosed acute myeloid leukemia.
Academic Article Targeting Acute Myeloid Leukemia Stem Cells Through Perturbation of Mitochondrial Calcium.
Academic Article Multi-gene measurable residual disease assessed by digital polymerase chain reaction has clinical and biological utility in acute myeloid leukemia patients receiving venetoclax/azacitidine.

Search Criteria
  • Leukemia Myeloid

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)